Who is sponsoring NCT00789152?

NCT00789152 is sponsored by Organon and Co.

What condition does NCT00789152 study?

NCT00789152 studies Allergic Rhinitis.

What drugs are being tested in NCT00789152?

Interventions: desloratadine, levocetirizine.

What is the status of NCT00789152?

NCT00789152 is currently COMPLETED.

Last reviewed 2024-08-15 · How we verify

The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)

NCT00789152 PHASE3 COMPLETED

This was a study to measure the ability of desloratadine and levocetirizine to decrease nasal obstruction in subjects who had study-induced allergic rhinitis. Study participants had allergic rhinitis symptoms induced in a Vienna Challenge Chamber and then received desloratadine or levocetirizine for 8 days. After at least a 10 to 35-day washout period (time when no drug is given), subjects received the opposite treatment for 8 days. Subjects had their total nasal symptom measured.on the 8th day of each treatment period.

Details

Lead sponsor	Organon and Co
Phase	PHASE3
Status	COMPLETED
Enrolment	81
Start date	Mon Dec 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat May 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Allergic Rhinitis

Interventions

desloratadine
levocetirizine